Diasorin’s Post

View organization page for Diasorin, graphic

70,281 followers

Diasorin is proud to create awareness of CMV along with the National CMV Foundation who are at the forefront of CMV education. Did you know that congenital CMV (cCMV) is the most common infectious cause of birth defects in the US and that one out of five babies with congenital CMV will develop long-term health problems, such as hearing loss?  Diasorin has assays that can support a physician’s diagnosis in two ways: The mother: The LIAISON® CMV assay panel (IgG, IgM) is a complete solution to aid clinicians in patient assessment of CMV. The diagnosis of Human Cytomegalovirus infection in pregnant women is of particular importance in assessing risk of fetal damage.  The baby: Diasorin’s Simplexa® Congenital CMV Direct assay is the only FDA-cleared PCR assay for the detection of CMV in both saliva swabs and urine. PCR testing in the first 3 weeks of life can aid in determining if an infant has congenital CMV. An early diagnosis allows for prompt treatment of hearing loss and provides an opportunity for early intervention for better health outcomes. Join the movement #hearthedifference with Diasorin as we do our part to ensure that babies get a chance to live healthy and happy lives and visit our website to learn more:  https://hubs.li/Q02CV8bV0 https://hubs.li/Q02CV2t30  #Diasorin #Diagnostictesting #congenitalCMV #CMV

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics